Advances in Immunotherapy: Tackling CAR T-cell Therapy Resistance
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
Tag: Cancer immunotherapy
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved the immunotherapeutic obinutuzumab (Gazyva) for...
Guest Post by Emer Smyth, PhD Assistant Director for the Stand Up To Cancer (SU2C) translational research grant programs, AACR
The AACR and Philadelphia Media Network co-hosted an event in January entitled, “Cancer Precision Medicine: Big Ideas in Research,...
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
It’s that time of year when we reflect on the progress we made over the past 12 months –...
This year has been a momentous year in healthcare, and, as some news outlets like Boston’s WBUR radio are...
On Monday, the U.S. Food and Drug Administration (FDA) rounded out an exciting month for the multiple myeloma community...
On Monday, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the immunotherapeutic...